Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Studer

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|April 28, 2006
Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimenBlair Capitano, Brian A Potoski, Shahid Husain, et al.
American Journal of Respiratory and Critical Care Medicine|July 12, 2008
CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipientsSean M Studer, M Patricia George, Xuehai Zhu, et al.
Transplantation|March 20, 2009
Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxisOriol Manuel, Deepali Kumar, George Moussa, et al.
The American Journal of Managed Care|July 19, 2017
Considerations for optimal management of patients with pulmonary arterial hypertension: a multi-stakeholder roundtable discussionSean M Studer, Martha Kingman, Luis Calo, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 24, 2007
Eleven years on: a clinical update of key areas of the 1996 lung allograft rejection working formulationGregory I Snell, Annette Boehler, Allan R Glanville, et al.
Plos One|May 30, 2009
Systemic inhibition of NF-kappaB activation protects from silicosisMichelangelo Di Giuseppe, Federica Gambelli, Gary W Hoyle, et al.
Transplantation|May 24, 2007
Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipientsShahid Husain, David L Paterson, Sean M Studer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 19, 2007
Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirinKashif Raza, Sameer B Ismailjee, Maria Crespo, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 23, 2011
Five-year outcomes with alemtuzumab induction after lung transplantationSusan Shyu, Mary Amanda Dew, Joseph M Pilewski, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 31, 2003
A review of lung transplant donor acceptability criteriaJonathan B Orens, Annette Boehler, Marc de Perrot, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|April 28, 2006
Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimenBlair Capitano, Brian A Potoski, Shahid Husain, et al.
American Journal of Respiratory and Critical Care Medicine|July 12, 2008
CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipientsSean M Studer, M Patricia George, Xuehai Zhu, et al.
Transplantation|March 20, 2009
Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxisOriol Manuel, Deepali Kumar, George Moussa, et al.
The American Journal of Managed Care|July 19, 2017
Considerations for optimal management of patients with pulmonary arterial hypertension: a multi-stakeholder roundtable discussionSean M Studer, Martha Kingman, Luis Calo, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 24, 2007
Eleven years on: a clinical update of key areas of the 1996 lung allograft rejection working formulationGregory I Snell, Annette Boehler, Allan R Glanville, et al.
Plos One|May 30, 2009
Systemic inhibition of NF-kappaB activation protects from silicosisMichelangelo Di Giuseppe, Federica Gambelli, Gary W Hoyle, et al.
Transplantation|May 24, 2007
Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipientsShahid Husain, David L Paterson, Sean M Studer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 19, 2007
Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirinKashif Raza, Sameer B Ismailjee, Maria Crespo, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 23, 2011
Five-year outcomes with alemtuzumab induction after lung transplantationSusan Shyu, Mary Amanda Dew, Joseph M Pilewski, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 31, 2003
A review of lung transplant donor acceptability criteriaJonathan B Orens, Annette Boehler, Marc de Perrot, et al.
Pageof 4